INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240091247A1
SERIAL NO

18271829

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an inhibitor against the stem cells of chronic myeloid leukemia (CML), a pharmaceutical composition for the treatment of CML having preventive effect on CML recurrence, a method of preventing CML recurrence, and a method of assessing the efficacy of treatment with a drug in a patient with CML, including a step of determining the expression level of latexin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OHARA PHARMACEUTICAL CO LTDSHIGA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kamachi, Kazuharu Saga-shi Saga, JP 2 0
Kimura, Shinya Saga-shi Saga, JP 50 394
Kurahashi, Yuki Koka-shi Shiga, JP 14 27
Ureshino, Hiroshi Saga-shi Saga, JP 2 0
Watanabe, Tatsuro Saga-shi Saga, JP 24 97
Yamamoto, Yuta Saga-shi Saga, JP 58 217

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation